Characterization of absorbable collagen sponges as recombinant human bone morphogenetic protein-2 carriers

被引:42
|
作者
Friess, W
Uludag, H
Foskett, S
Biron, R
Sargeant, C
机构
[1] Univ Erlangen Nurnberg, Dept Pharmaceut Technol, D-91058 Erlangen, Germany
[2] Univ Alberta, Dept Biomed Engn, Edmonton, AB T6G 2G3, Canada
[3] Genet Inst Inc, Andover, MA 01810 USA
关键词
collagen; bone morphogenetic protein; sterilization; crosslinking;
D O I
10.1016/S0378-5173(99)00128-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For clinical use recombinant human bone morphogenetic protein-2 (rhBMP-2) is soaked onto an absorbable collagen sponge (ACS) for bone regeneration. Therefore, loss of rhBMP-2 upon mechanical handling during implantation and a potential effect of the carrier on in vivo retention is of interest. The interactions between drug and carrier were looked at from the application mode and the amount of protein which can be mechanically expressed from the combination was investigated. The results indicated that rhBMP-2 binds to the collagen system. The most hydrophilic double extended homodimer showed the least binding affinity to ACS. By extending the waiting time between soaking and implantation, protein incorporation could be increased. In addition, the amount of rhBMP-2 which could be expressed was reduced by heavier ACS material and allowed for a shorter waiting period, especially at lower rhBMP-2 concentration. Crosslinking of ACS with formaldehyde led to reduced binding of rhBMP-2 to collagen either by direct hindrance of binding or reduction in swelling and number of binding sites available. Higher product pH or anion concentration enabled to increase rhBMP-2 incorporation but was limited by the potential precipitation of rhBMP-2. Despite a variety of chemical changes of ACS by ethylene oxide sterilization incorporation was not changed significantly. The in vivo release kinetics of I-125-rhBMP-2 from the collagen sponge were studied using a rat ectopic implant model. The ACS/rhBMP-2 systems tested demonstrated small but significant differences in the in vivo retention of rhBMP-2. Consequently, it is important to have as little variability in pH, anion concentration, crosslinking, and ACS mass as possible to achieve consistent or maximum binding and to avoid rhBMP-2 precipitation. Furthermore, these characteristics can be important for other in vivo applications. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:51 / 60
页数:10
相关论文
共 50 条
  • [31] Effect of elcatonin on osteoinduction by recombinant human bone morphogenetic protein-2
    Okubo, Y
    Bessho, K
    Fujimura, K
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) : 317 - 321
  • [32] Sustained release emphasizing recombinant human bone morphogenetic protein-2
    Winn, SR
    Uludag, H
    Hollinger, JO
    ADVANCED DRUG DELIVERY REVIEWS, 1998, 31 (03) : 303 - 318
  • [33] Occipitocervical fusion using recombinant human bone morphogenetic protein-2
    Shahlaie, Kiarash
    Kim, Kee D.
    SPINE, 2008, 33 (21) : 2361 - 2366
  • [34] Osteogenesis by recombinant human bone morphogenetic protein-2 at skeletal sites
    Okubo, Y
    Bessho, K
    Fujimura, K
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2000, (375) : 295 - 301
  • [35] Can a low dosage of recombinant human bone morphogenetic protein-2 loaded on collagen sponge induce ectopic bone?
    Alruwaili, Mohammed Katib
    Sugaya, Tsutomu
    Morimoto, Yasuhito
    Nakanishi, Ko
    Akasaka, Tsukasa
    Yoshida, Yasuhiro
    DENTAL MATERIALS JOURNAL, 2023, 42 (03) : 433 - 440
  • [36] Comparative study of recombinant human bone morphogenetic protein-2 carriers in rat subcutaneous tissues: Pilot study
    Lee, Sunkyu
    Choi, Hyunmin
    Shim, June-Sung
    Chung, Moon-Kyu
    Park, Young-Bum
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2015, 12 : 138 - 146
  • [37] Silk Fibroin Microparticles as Carriers for Delivery of Human Recombinant Bone Morphogenetic Protein-2: In Vitro and In Vivo Bioactivity
    Bessa, Paulo Cesar
    Balmayor, Elizabeth R.
    Hartinger, Joachim
    Zanoni, Gerald
    Dopler, Daniela
    Meinl, Alexandra
    Banerjee, Asmita
    Casal, Margarida
    Redl, Heinz
    Reis, Rui L.
    van Griensven, Martijn
    TISSUE ENGINEERING PART C-METHODS, 2010, 16 (05) : 937 - 945
  • [38] Comparative study of recombinant human bone morphogenetic protein-2 carriers in rat subcutaneous tissues: Pilot study
    Sunkyu Lee
    Hyunmin Choi
    June-Sung Shim
    Moon-Kyu Chung
    Young-Bum Park
    Tissue Engineering and Regenerative Medicine, 2015, 12 : 138 - 146
  • [39] Two lyophilized polymer matrix recombinant human bone morphogenetic protein-2 carriers in rabbit calvarial defects
    Rodgers, JB
    Vasconez, HC
    Wells, MD
    DeLuca, PP
    Faugere, MC
    Fink, BF
    Hamilton, D
    JOURNAL OF CRANIOFACIAL SURGERY, 1998, 9 (02) : 147 - 153
  • [40] Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs
    Choi, SH
    Kim, CK
    Cho, KS
    Huh, JS
    Sorensen, RG
    Wozney, JM
    Wikesjö, UME
    JOURNAL OF PERIODONTOLOGY, 2002, 73 (01) : 63 - 72